David Ulmert

Title: Biography of Inventor David Ulmert

Introduction: David Ulmert is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of cancer diagnostics and therapeutics. He holds a total of three patents that focus on innovative methods for monitoring and treating prostate cancer.

Latest Patents: One of his latest patents is titled "Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer." This invention provides methods for monitoring and measuring tumor-associated free PSA ('fPSA') using antibody polypeptides, which serve as indicators of androgen receptor signaling. The methods can assess the efficacy of anti-androgen and general anti-cancer treatments. Additionally, it includes various compositions and therapeutic methods involving anti-fPSA antibodies. Another notable patent is "Systems and methods for determining optimum patient-specific antibody dose for tumor targeting." This disclosure describes a non-linear compartmental model that utilizes PET-derived data to predict the optimal therapeutic dose of cargo-carrying antibodies, enhancing the therapeutic indices of radiolabeled antibodies.

Career Highlights: David has worked with esteemed organizations such as Memorial Sloan Kettering Cancer Center and Diaprost Ab. His work has significantly impacted the development of cancer treatment strategies, particularly in optimizing therapeutic approaches for patients.

Collaborations: Throughout his career, David has collaborated with notable professionals in the field, including Charles L. Sawyers and